Table 2.
Medication | Dosage | Results |
---|---|---|
Lidocaine | 1–2 mg/kg of body weight IV for 3–4 min | Complete or partial suppression |
Amitriptyline | 50–100 mg/day for 6 weeks | Decreased intensity and subjective relief |
Nortriptyline | 50–150 mg/day for 6 weeks | Decreased loudness |
Sertraline | 25–50 mg/day for 16 weeks | Decreased loudness and severity |
Gabapentin | 2400 mg/day for 20 weeks *** | Decreased annoyance |
Alprazolam | 0.25–0.5 mg/day for 1 week. Max 1 mg/day *** | Decreased loudness |
Clonazepam | Not applicable | Decreased annoyance and intensity |
Acamprosate | 333 mg TID for 3 months *** | Improvements |
Neramexane | 25–75 mg/day for 16 weeks | Decreased annoyance |
Betahistine | 48 mg/day for 3 months | Slight improvement in loudness and tinnitus handicap inventory |
Cilostazol | 200 mg/day for 4 weeks | Decreased Visual Analogue Scale score |
Melatonin | 3 mg/day for 30 days | Decreased tinnitus intensity in patients with insomnia |
Misoprostol | Increasing dosage for 4 months | Decreased loudness |
Ondansetron | 16 mg/day for 4 weeks | Improvements in tinnitus severity index score |
Oxytocin | 16 IU single dose | Decreased Clinical Global Impressions score |
Pramipexole | Max dose of 0.7 mg TID for 4 weeks | Decreased annoyance |
Vitamin B12 | 2500μg weekly for 6 weeks *** | Improvements in patients with vitamin B12 deficiency |
Paroxetine, Trimipramine, Carbamazepine, Lamotrigine, Baclofen, Diazepam, Memantine, Cyclandelate, G. biloba, Piribedil, Vardenafil | No significant difference |
*** No significant difference at lower doses and with shorter duration of treatment.